Accessibility Menu
 
Compugen logo

Compugen

(NASDAQ) CGEN

Current Price$2.58
Market Cap$243.95M
Since IPO (2000)-78%
5 Year-69%
1 Year+113%
1 Month+13%

Compugen Financials at a Glance

Market Cap

$243.95M

Revenue (TTM)

$72.76M

Net Income (TTM)

$35.34M

EPS (TTM)

$0.37

P/E Ratio

6.99

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Price

$2.58

Volume

765,695.544

Open

$2.48

Previous Close

$2.58

Daily Range

$2.41 - $2.65

52-Week Range

$1.23 - $2.65

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Compugen

Industry

Biotechnology

Employees

75

CEO

Eran Ophir, PhD

Headquarters

Holon, 5885849, IL

CGEN Financials

Key Financial Metrics (TTM)

Gross Margin

87%

Operating Margin

43%

Net Income Margin

49%

Return on Equity

45%

Return on Capital

23%

Return on Assets

23%

Earnings Yield

14.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$243.95M

Shares Outstanding

94.55M

Volume

765.70K

Short Interest

0.00%

Avg. Volume

361.59K

Financials (TTM)

Gross Profit

$63.51M

Operating Income

$31.33M

EBITDA

$31.80M

Operating Cash Flow

$31.63M

Capital Expenditure

$306.00K

Free Cash Flow

$31.33M

Cash & ST Invst.

$145.64M

Total Debt

$2.96M

Compugen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$67.33M

+4477.3%

Gross Profit

$63.80M

+7914.6%

Gross Margin

94.75%

N/A

Market Cap

$243.95M

N/A

Market Cap/Employee

$3.30M

N/A

Employees

74

N/A

Net Income

$56.84M

+1029.3%

EBITDA

$56.04M

+848.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$142.68M

+42.2%

Accounts Receivable

$294.00K

+9.3%

Inventory

$0.00

N/A

Long Term Debt

$2.44M

-1.0%

Short Term Debt

$521.00K

+16.3%

Return on Assets

22.53%

N/A

Return on Invested Capital

23.32%

N/A

Free Cash Flow

$31.33M

N/A

Operating Cash Flow

$31.63M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVCTNuvectis Pharma, Inc.
$8.22+0.74%
MISTMilestone Pharmaceuticals Inc.
$2.02+0.50%
TNXPTonix Pharmaceuticals Holding Corp.
$12.48-4.00%
MOLNMolecular Partners AG
$4.20-3.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About CGEN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.